Roche Holding AGRoche launches new cyclospora PCR tests amid U.S. outbreak, expanding product portfolio and supporting public health response

Roche has launched two new real-time PCR tests for detecting the Cyclospora cayetanensis parasite as an outbreak continues to spread throughout the United States. The LightMix Modular Cyclospora assay provides specific detection of cyclospora only, while the LightMix OneTube Gastro Para 2 assay is a multiplex test that also detects Entamoeba histolytica, Giardia, Dientamoeba fragilis, Cryptosporidium, and Blastocystis. These research-use-only tests expand Roche's cyclospora portfolio, offering laboratories flexible and cost-effective options on the LightCycler 480 and LightCycler PRO instruments. The launch builds on Roche's existing UC-TIB-Gastro-PARA-2 assay, a high-throughput multiplex test for the cobas 5800, 6800, and 8800 systems, and underscores the company's commitment to supporting public health responses to infectious disease outbreaks.
Roche Holding AGRoche launches new cyclospora PCR tests amid U.S. outbreak, expanding product portfolio and supporting public health response
Rogers Corporation